One week left! Frost & Sullivan invites you to attend the Synthetic Biology and Biomanufacturing Forum to embark on a new journey in industrial development.

Today, biomanufacturing has become a shining star in the capital market. Synthetic biology, as the third life science revolution following the discovery of the DNA double helix structure and the genomic technology revolution, is leadingFrost & Sullivan China Frost & Sullivanthe biomanufacturing industry to rapidly enter the 4.0 era, becoming a crucial strategic pillar for reshaping global material production methods. In the future, it will deeply transform the development paradigms of biomedicine, advanced materials, consumer goods, energy, environmental protection, agriculture, and other industries. Promoting synthetic biology and biomanufacturing is not only a strategic opportunity to seize global leadership positions but also an important path to accelerate the formation of new productive forces and achieve high-level technological self-sufficiency.

On August 4, Frost & Sullivan will host the 20th Frost & Sullivan Global Growth, Innovation and Leadership Summit and the 5th New Investment Conference, and for the first time, a special forum on synthetic biology and biomanufacturing will be launched. Registration is now open.

As a core professional forum focusing on cutting-edge biotech at this summit, the Synthetic Biology and Biomanufacturing Forum will bring together academicians from two academies, top scholars, university professors, industry experts, leading enterprises, and investment institutions. Through keynote speeches, panel discussions, and white paper releases, a integrated communication platform of "industry-university-research-finance-use-service" will be established. This forum will comprehensively showcase the industrial value of the "third biotechnology revolution" in synthetic biology, providing strong support for technological innovation, achievement transformation, ecosystem improvement, and global development of China’s biomanufacturing industry.

Scan the QR code to register immediately

Frost & Sullivan will continue the research project of last year’s "Shanghai Synthetic Biology and Biomanufacturing Industry Development White Paper (2025)", and jointly release the "Global and Chinese Synthetic Biology and Biomanufacturing Industry Development White Paper (2026)" with the National Biomanufacturing Industry Innovation Center for the first time. This white paper will systematically outline the development landscape of global synthetic biology and biomanufacturing industries. Through close cooperation among "government-industry-university-research-finance-use" and in-depth research results, it aims to provide forward-looking structured insights and references for government agencies, investment institutions, the industry, and all sectors of society.

In particular, for the chapters on upstream and downstream industrial chains and benchmark cases (parks, enterprises, industry platforms, etc.), we invite relevant enterprises to cooperate. They can share from a first-person perspective how to address existing challenges and capitalize on business opportunities, demonstrating their business models, technology platforms, advanced processes, and ecological partnerships. These empirical cases will provide authoritative voices and focused dissemination opportunities for cooperative enterprises, while also offering references for investors, research institutions, and the industry, attracting upstream and downstream partners to join the enterprise ecosystem. Participating in this white paper project helps enhance the brand presence of cooperative enterprises in the global market and supports global brand building and product layout.

Two strategic cooperation agreements will be held at this forum to promote deep integration of "industry-university-research-use", and break down barriers to innovative development in the synthetic biology field. At the forum, Frost & Sullivan will officially sign a strategic cooperation agreement with the National Biomanufacturing Industry Innovation Center. Based on the development needs of synthetic biology and biomanufacturing industries, both parties will focus on core areas such as technological innovation implementation, industrial ecosystem construction, industry research empowerment, and project achievement transformation, carrying out comprehensive and deep long-term strategic cooperation to jointly promote high-quality upgrading of the synthetic biology and biomanufacturing industries.

At the same time, Frost & Sullivan will hold school-enterprise strategic cooperation agreement ceremonies with the University of Electronic Science and Technology and Fudan University, fully integrating industry service advantages with top academic research and talent resources from universities, establishing a dedicated industry-university-research collaborative innovation system. They will focus on key areas such as AI+BIO cutting-edge technology research, innovation achievement implementation, joint talent training, and industry innovation application exploration, striving to overcome technical bottlenecks and industry pain points in the integration of AI and biomanufacturing, and officially starting a new chapter of mutual empowerment between schools and enterprises in AI&BIO innovative development.

Two important panel discussions will be held at this forum, bringing together industry leaders, innovative enterprises, and frontline investment institutions to conduct in-depth discussions and intellectual exchanges on two cutting-edge topics.

Focusing on investment opportunities and real challenges in the synthetic biology and biomanufacturing sector, this discussion will explore sustainable development paths for the industry. The panel includes industry innovative enterprises and industrial capital representatives, such as Yuguan Biotechnology,Huaxi Tang'an BiotechnologyJuyuan Yuanchuang, and other leading enterprises in various fields, as well as relevant national guidance fund institutions. Guests will combine a capital perspective with frontline industrialization practices to analyze the development bottlenecks of biomanufacturing projects and explore investment logic and solutions that balance long-term technology research and commercialization.

This panel discussion will focus on the integration trend of AI and synthetic biology, discussing AI&BIO technology implementation scenarios, innovation opportunities, and development boundaries. Leading enterprises such as Jinbo Biotech,InSilicon IntelligenceEnhe Technology, and Abio Yi will join professional investment institutions like Lenovo Venture Capital to participate in the discussion. All parties will rely on project practice and cutting-edge investment perspectives to discuss how AI can reshape the biotech research chain and accelerate innovation achievement transformation, exploring new growth opportunities in cross-sectoral tracks.

📞 Conference Consultation Hotline:

021-3209-6800 ext. 8672

📧 Conference Consultation Email:

gil@frostchina.com